title: The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC).
abstract: Agents that have shown improvements in survival in mCRPC now include abiraterone, enzalutamide, docetaxel, cabazitaxel and radium-223. Bone supportive agents and palliative radiation continue to play an important role in the overall management of mCRPC. Given the complexity, variety and importance of optimizing the use of these agents, a multidisciplinary team approach is highly recommended.
authors.affiliation: Centre Hospitalier de l'Université de Montréal, Montréal, QC;
authors.forename: Fred
authors.initials: F
authors.lastname: Saad
authors.affiliation: BC Cancer Agency, Vancouver, BC;
authors.forename: Kim N
authors.initials: KN
authors.lastname: Chi
authors.affiliation: University of Toronto, Princess Margaret Cancer Centre, Toronto, ON;
authors.forename: Antonio
authors.initials: A
authors.lastname: Finelli
authors.affiliation: Juravinski Cancer Centre, McMaster University, Hamilton, ON;
authors.forename: Sebastien J
authors.initials: SJ
authors.lastname: Hotte
authors.affiliation: Western University, London, ON;
authors.forename: Jonathan
authors.initials: J
authors.lastname: Izawa
authors.affiliation: McMaster University, Hamilton, ON;
authors.forename: Anil
authors.initials: A
authors.lastname: Kapoor
authors.affiliation: McGill University Health Center, Montreal, QC;
authors.forename: Wassim
authors.initials: W
authors.lastname: Kassouf
authors.affiliation: Sunnybrook Health Sciences Centre, Toronto, University of Toronto, ON;
authors.forename: Andrew
authors.initials: A
authors.lastname: Loblaw
authors.affiliation: BC Cancer Agency, Vancouver, BC; ; Cross Cancer Institute, University of Alberta, Edmonton, AB;
authors.forename: Scott
authors.initials: S
authors.lastname: North
authors.affiliation: Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, NS;
authors.forename: Ricardo
authors.initials: R
authors.lastname: Rendon
authors.affiliation: University of British Columbia, Vancouver, BC;
authors.forename: Alan
authors.initials: A
authors.lastname: So
authors.affiliation: Cross Cancer Institute, University of Alberta, Edmonton, AB;
authors.forename: Nawaid
authors.initials: N
authors.lastname: Usmani
authors.affiliation: l'Hotel-Dieu de Quebec, Université de Laval, Quebec City, QC.
authors.forename: Eric
authors.initials: E
authors.lastname: Vigneault
authors.affiliation: University of Toronto, Princess Margaret Cancer Centre, Toronto, ON;
authors.forename: Neil E
authors.initials: NE
authors.lastname: Fleshner